Cash & equivalents increased 26.3%
Cash & equivalents changed +26.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +26.3% from the comparable as-filed period.
Gross profit changed -100.8% from the comparable as-filed period.
Inventory changed +22.2% from the comparable as-filed period.
Operating income changed +31.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -54.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -22.0% from the comparable as-filed period.
Stock-based compensation changed -52.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -0.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.